|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 95,783.33 CHF | +0.36% |
|
+1.69% | -17.92% |
| 06-12 | Goldman Sachs Lowers Lindt & Spruengli's PT, Affirms Sell Rating | MT |
| 05-21 | Morgan Stanley Upgrades Lindt & Sprüngli to Equalweight, Reduces PT | MT |
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 4.77 | 5.58 | 6.54 | 6.66 | 6.71 | |||||
Return on Total Capital | 6.35 | 7.51 | 8.99 | 9.31 | 9.26 | |||||
Return On Equity % | 9.98 | 11.84 | 15.51 | 14.78 | 14.84 | |||||
Return on Common Equity | 9.99 | 11.84 | 15.51 | 14.78 | 14.85 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 67.08 | 66.44 | 67.39 | 65.69 | 62.78 | |||||
SG&A Margin | 47.22 | 46.06 | 46.47 | 44.39 | 41.43 | |||||
EBITDA Margin % | 17.9 | 18.55 | 19.14 | 19.49 | 19.52 | |||||
EBITA Margin % | 14.28 | 15.25 | 15.96 | 16.47 | 16.6 | |||||
EBIT Margin % | 14.07 | 15.08 | 15.8 | 16.33 | 16.47 | |||||
Income From Continuing Operations Margin % | 10.64 | 11.4 | 12.83 | 12.12 | 12.21 | |||||
Net Income Margin % | 10.64 | 11.4 | 12.83 | 12.12 | 12.22 | |||||
Net Avail. For Common Margin % | 10.64 | 11.4 | 12.83 | 12.12 | 12.22 | |||||
Normalized Net Income Margin | 8.48 | 9.14 | 9.57 | 9.84 | 9.8 | |||||
Levered Free Cash Flow Margin | 10.61 | 8.36 | 7.07 | 9.46 | 4.19 | |||||
Unlevered Free Cash Flow Margin | 10.96 | 8.73 | 7.47 | 9.98 | 4.73 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 0.54 | 0.59 | 0.66 | 0.65 | 0.65 | |||||
Fixed Assets Turnover | 2.62 | 2.82 | 2.98 | 3.01 | 3.02 | |||||
Receivables Turnover (Average Receivables) | 5.33 | 5.38 | 5.33 | 5.01 | 4.99 | |||||
Inventory Turnover (Average Inventory) | 2.08 | 2.05 | 1.9 | 2.04 | 2.08 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 2.04 | 1.83 | 1.42 | 1.77 | 1.83 | |||||
Quick Ratio | 1.51 | 1.25 | 0.88 | 1.18 | 1.15 | |||||
Operating Cash Flow to Current Liabilities | 0.56 | 0.48 | 0.42 | 0.59 | 0.3 | |||||
Days Sales Outstanding (Average Receivables) | 68.47 | 67.87 | 68.45 | 73.02 | 73.09 | |||||
Days Outstanding Inventory (Average Inventory) | 175.89 | 178.09 | 192.23 | 179.04 | 175.65 | |||||
Average Days Payable Outstanding | 49.18 | 53.82 | 62.12 | 68.58 | 56.17 | |||||
Cash Conversion Cycle (Average Days) | 195.17 | 192.14 | 198.56 | 183.48 | 192.57 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 28.38 | 32.64 | 33.02 | 34.39 | 35.61 | |||||
Total Debt / Total Capital | 22.1 | 24.61 | 24.82 | 25.59 | 26.26 | |||||
LT Debt/Equity | 26.74 | 30.91 | 25.24 | 32.38 | 32.6 | |||||
Long-Term Debt / Total Capital | 20.83 | 23.31 | 18.97 | 24.09 | 24.04 | |||||
Total Liabilities / Total Assets | 41.68 | 44.61 | 45.83 | 47.15 | 45.52 | |||||
EBIT / Interest Expense | 25.55 | 25.38 | 24.6 | 19.66 | 18.81 | |||||
EBITDA / Interest Expense | 35.5 | 33.76 | 32.06 | 25.21 | 23.97 | |||||
(EBITDA - Capex) / Interest Expense | 26.96 | 26.85 | 23.71 | 19.38 | 18.76 | |||||
Total Debt / EBITDA | 1.64 | 1.43 | 1.31 | 1.43 | 1.41 | |||||
Net Debt / EBITDA | 0.33 | 0.57 | 0.88 | 0.56 | 0.88 | |||||
Total Debt / (EBITDA - Capex) | 2.16 | 1.8 | 1.76 | 1.86 | 1.81 | |||||
Net Debt / (EBITDA - Capex) | 0.43 | 0.72 | 1.18 | 0.73 | 1.12 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | 14.3 | 8.41 | 4.64 | 6.08 | 7.24 | |||||
Gross Profit, 1 Yr. Growth % | 18.38 | 7.38 | 6.14 | 3.4 | 2.5 | |||||
EBITDA, 1 Yr. Growth % | 35.73 | 12.36 | 7.96 | 8.09 | 7.42 | |||||
EBITA, 1 Yr. Growth % | 46.88 | 15.76 | 9.48 | 9.59 | 8.03 | |||||
EBIT, 1 Yr. Growth % | 47.77 | 16.16 | 9.66 | 9.68 | 8.16 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | 53.23 | 16.15 | 17.85 | 0.13 | 8.09 | |||||
Net Income, 1 Yr. Growth % | 52.47 | 16.15 | 17.85 | 0.13 | 8.17 | |||||
Normalized Net Income, 1 Yr. Growth % | 50.59 | 16.78 | 9.62 | 9.08 | 6.88 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | 52.76 | 18.21 | 19.77 | 1.35 | 8.25 | |||||
Accounts Receivable, 1 Yr. Growth % | 8.52 | 6.46 | 4.68 | 18.71 | 0.03 | |||||
Inventory, 1 Yr. Growth % | 8.57 | 14.97 | 5.24 | 2.15 | 26.43 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | 2.72 | -0.84 | -1.32 | 10.97 | 3.69 | |||||
Total Assets, 1 Yr. Growth % | 11.24 | -11.29 | -1.07 | 16.5 | -0.64 | |||||
Tangible Book Value, 1 Yr. Growth % | 18.63 | -21.34 | -1.92 | 16.65 | 6.96 | |||||
Common Equity, 1 Yr. Growth % | 13.54 | -15.76 | -3.25 | 13.67 | 2.41 | |||||
Cash From Operations, 1 Yr. Growth % | 4.98 | -8.56 | 2.99 | 51.81 | -55.97 | |||||
Capital Expenditures, 1 Yr. Growth % | -3.9 | -5.44 | 36.63 | -4.1 | 0.93 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | -15.58 | -14.64 | -11.5 | 42.07 | -52.54 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | -15.36 | -13.64 | -10.45 | 41.81 | -49.12 | |||||
Dividend Per Share, 1 Yr. Growth % | 9.09 | 8.33 | 7.69 | 7.14 | 20 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | 0.95 | 11.32 | 6.51 | 5.35 | 6.66 | |||||
Gross Profit, 2 Yr. CAGR % | 1.37 | 12.75 | 6.76 | 4.75 | 2.95 | |||||
EBITDA, 2 Yr. CAGR % | -1.85 | 23.49 | 10.14 | 7.99 | 7.75 | |||||
EBITA, 2 Yr. CAGR % | -2.2 | 30.39 | 12.58 | 9.5 | 8.81 | |||||
EBIT, 2 Yr. CAGR % | -2.22 | 31.02 | 12.86 | 9.63 | 8.92 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | -2.11 | 33.41 | 17 | 8.63 | 4.04 | |||||
Net Income, 2 Yr. CAGR % | -1.89 | 33.08 | 17 | 8.63 | 4.07 | |||||
Normalized Net Income, 2 Yr. CAGR % | -1.36 | 32.61 | 13.14 | 9.31 | 7.98 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | -2.49 | 34.38 | 18.99 | 10.18 | 4.74 | |||||
Accounts Receivable, 2 Yr. CAGR % | -4.12 | 7.48 | 5.56 | 11.48 | 8.97 | |||||
Inventory, 2 Yr. CAGR % | 0.76 | 11.72 | 10 | 3.68 | 13.64 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 0.27 | 0.93 | -1.08 | 4.64 | 7.27 | |||||
Total Assets, 2 Yr. CAGR % | 5.54 | -0.66 | -6.32 | 7.36 | 7.59 | |||||
Tangible Book Value, 2 Yr. CAGR % | 9.03 | -3.4 | -12.16 | 6.96 | 11.7 | |||||
Common Equity, 2 Yr. CAGR % | 5.88 | -2.2 | -9.72 | 4.87 | 7.89 | |||||
Cash From Operations, 2 Yr. CAGR % | -0.25 | -2.03 | -2.96 | 25.04 | -18.25 | |||||
Capital Expenditures, 2 Yr. CAGR % | 1.82 | -4.67 | 13.67 | 14.47 | -1.62 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | -7.14 | -15.11 | -13.08 | 12.08 | -17.88 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | -7.41 | -14.51 | -12.06 | 12.64 | -15.06 | |||||
Dividend Per Share, 2 Yr. CAGR % | 6.9 | 8.71 | 8.01 | 7.42 | 13.39 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | 2.1 | 3.38 | 9.05 | 6.36 | 5.98 | |||||
Gross Profit, 3 Yr. CAGR % | 2.19 | 3.34 | 10.5 | 5.62 | 4 | |||||
EBITDA, 3 Yr. CAGR % | 0.77 | 2.67 | 18.08 | 9.43 | 7.8 | |||||
EBITA, 3 Yr. CAGR % | 0.57 | 3.46 | 23.01 | 11.55 | 9.01 | |||||
EBIT, 3 Yr. CAGR % | 0.57 | 3.56 | 23.47 | 11.77 | 9.14 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | 0.23 | 3.63 | 28.01 | 11.08 | 8.45 | |||||
Net Income, 3 Yr. CAGR % | 0.37 | 3.79 | 27.79 | 11.08 | 8.48 | |||||
Normalized Net Income, 3 Yr. CAGR % | 0.38 | 4.35 | 24.46 | 11.74 | 8.49 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | 0.19 | 3.97 | 29.32 | 12.79 | 9.53 | |||||
Accounts Receivable, 3 Yr. CAGR % | -4.35 | -0.71 | 6.54 | 9.78 | 7.52 | |||||
Inventory, 3 Yr. CAGR % | 0.41 | 5.29 | 9.52 | 7.32 | 10.77 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 9.86 | -0.1 | 0.17 | 2.79 | 4.32 | |||||
Total Assets, 3 Yr. CAGR % | 7.3 | -0.4 | -0.8 | 0.74 | 4.62 | |||||
Tangible Book Value, 3 Yr. CAGR % | 8.1 | -2.21 | -2.91 | -3.45 | 6.96 | |||||
Common Equity, 3 Yr. CAGR % | 5.27 | -1.89 | -2.55 | -2.51 | 4.04 | |||||
Cash From Operations, 3 Yr. CAGR % | 8.26 | -3.1 | -0.38 | 12.65 | -11.7 | |||||
Capital Expenditures, 3 Yr. CAGR % | -3.94 | -0.66 | 7.48 | 7.41 | 9.76 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | 18.93 | -9.71 | -13.92 | 2.35 | -15.84 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | 18.63 | -9.54 | -13.18 | 3.09 | -13.58 | |||||
Dividend Per Share, 3 Yr. CAGR % | 6.27 | 7.38 | 8.37 | 7.72 | 11.46 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 3.33 | 4.02 | 3.84 | 4.16 | 8.08 | |||||
Gross Profit, 5 Yr. CAGR % | 4.04 | 4.38 | 3.99 | 3.9 | 7.41 | |||||
EBITDA, 5 Yr. CAGR % | 3.19 | 4.18 | 4.42 | 4.77 | 13.82 | |||||
EBITA, 5 Yr. CAGR % | 2.82 | 4.66 | 5.21 | 5.83 | 17.1 | |||||
EBIT, 5 Yr. CAGR % | 2.84 | 4.76 | 5.32 | 5.95 | 17.41 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | 3.16 | 4.71 | 6.63 | 5.6 | 17.82 | |||||
Net Income, 5 Yr. CAGR % | 3.17 | 4.8 | 6.72 | 5.7 | 17.72 | |||||
Normalized Net Income, 5 Yr. CAGR % | 2.41 | 4.66 | 5.3 | 6.3 | 17.56 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | 2.71 | 4.89 | 7.32 | 6.41 | 18.87 | |||||
Accounts Receivable, 5 Yr. CAGR % | -2.08 | -1.87 | -0.5 | 3.99 | 7.51 | |||||
Inventory, 5 Yr. CAGR % | 2.98 | 3.66 | 4.14 | 4.65 | 11.15 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 7.53 | 6.52 | 5.35 | 1.77 | 2.95 | |||||
Total Assets, 5 Yr. CAGR % | 6.86 | 2.64 | 1.63 | 2.63 | 2.48 | |||||
Tangible Book Value, 5 Yr. CAGR % | 11.79 | 1.87 | -0.51 | 1.36 | 2.69 | |||||
Common Equity, 5 Yr. CAGR % | 7.33 | 1 | -1 | 0.76 | 1.5 | |||||
Cash From Operations, 5 Yr. CAGR % | 9.91 | 5.05 | 3.63 | 7.3 | -7.95 | |||||
Capital Expenditures, 5 Yr. CAGR % | 0.03 | 3.46 | 2.75 | 5.14 | 3.75 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | 15.31 | 6.03 | 4.91 | -1.56 | -15.55 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | 15.21 | 6.3 | 5.24 | -1.25 | -13.95 | |||||
Dividend Per Share, 5 Yr. CAGR % | 6.4 | 6.93 | 6.96 | 7.39 | 10.35 |
- Stock Market
- Stocks
- LISN Stock
- 0QKN Stock
- Financials Lindt
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions
















